Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/8e7cf497-e8fb-443e-b08c-7ffcb3c2daf2/
EBS
Emergent Biosolutions IncSnapshot 2026-07-26 · 0.9w · Fresh
Strategy Eligibility
8 of 23 passing
★
OS Composite
OS 0.860
↗
Trending Value
✗
◆
Quality × Value
QV 0.805
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
VC2 4
📐
EBITDA/EV
19.6%
◐
Veiled Value
✗
▣
Piotroski Bargains
F7
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
9.0%
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 90%
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 0.99
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
90.0%ile
P/S
0.6×
P/B
0.7×
E/P
0.0750
FCF Yield
0.204
EBITDA/EV
0.196
SH Yield
0.090
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
5.00000000
/100 — 1=cheapest
VC2 (Trending Value)
4.00000000
/100
VC3 (Buyback)
3.00000000
/100
FCF yield of 20.4% is strong — the business generates significant free cash relative to price. VC2 score of 4.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
72.0%ile
ROE
-0.016
ROA
-0.007
Net Margin
-0.013
Op Margin
0.087
GPA
0.228
D/E
1.52
Current
4.29
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.299
Stability
6.897
lower=better
Accruals
-0.119
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
31.0%ile
6M Return
-39.2%
12M Return
1.3%
12-1 Mom
19.0%
Risk-Adj
0.23
Vol 252d
82.3%
Vol 60d
134.0%
↑ Expanding
Max DD 12M
-44.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (134%) is expanding vs long-term (82%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.86
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
94.6%
Sector Quality %ile
80.2%
P/B z-score
-0.28
Sector Avg OS
64.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (90th) and quality (72th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Strong Capital Return
Shareholder yield 9.0% backed by 20.4% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (134%) significantly exceeds 252-day (82%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
90.6% avg (6 factors)
Quality
D
44.9% avg (8 factors)
Momentum
D
31.0% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.860 | —8 | — | |
| Value %ile | 0.900 | —8 | — | |
| Quality %ile | 0.720 | —8 | — | |
| Momentum %ile | 0.310 | —0 | — | |
| F-Score | 7.000 | —8 | — | |
| Confidence | 0.871 | —8 | — | |
| Volatility | 0.823 | —8 | — |
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Earnings Yield (E/P)
0.0750
Price / Sales
0.55
Price / Book
0.72
Price / Cash Flow
2.53
FCF Yield
20.4%
EBITDA / EV
19.6%
Sales Yield (1/P·S)
0.8590
Shareholder Yield
Div + net buyback / mktcap
9.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-1.6%
Return on Assets
-0.7%
Net Margin
-1.3%
Operating Margin
8.7%
Gross Profit / Assets
Novy-Marx GPA
22.8%
Debt / Equity
1.52
Current Ratio
4.29
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.119
External Financing
Net issuance — lower=better
0.026
MomentumPrice trend strength over different horizons
6M Return
-39.2%
12M Return
1.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
19.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.23
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-29.9%
Earnings Stability (CV)
Lower = more stable
6.897
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Buyback Yield
9.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
5
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
4
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
3
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
91
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity